Gastro-esophageal Reflux Disease (GERD) Completed Phase Trials for Esomeprazole (DB00736)

Also known as: Gastroesophageal Reflux Disease / Gastro-esophageal Reflux Disease / GERD / GERD Gastroesophageal Reflux Disease / Gastro-Oesophageal Reflux Disease / Gastrooesophageal reflux disease / GERD (Gastroesophageal Reflux Disease) / Esophageal Reflux / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Gastro-esophageal Reflux Diseases / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

IndicationStatusPhase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00786695Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCPDiagnostic
NCT00524251The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
NCT01079884Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving PerformanceHealth Services Research
NCT01710800Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor TherapyDiagnostic
NCT02555852Proton Pump Inhibitors and Risk of Community-acquired Pneumonia